Search

Search Constraints

You searched for: Author/Creator Nayar, Saba

Search Results

1. 04.23 Identification of a novel subset of pathogenic stromal cells with key effector functions in tissue inflammation and damage. (1st March 2017)

2. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome. (19th September 2020)

3. AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (PSS). (June 2019)

7. CXCL13 as biomarker for histological involvement in Sjögren's syndrome. (4th July 2019)

8. History of tonsillectomy is associated with glandular inflammation in Sjögren's disease. (25th February 2022)

10. Intratumoral accumulation of podoplanin-expressing lymph node stromal cells promote tumor growth through elimination of CD4+ tumor-infiltrating lymphocytes. (1st September 2016)